RxDoctor Payments Data

Lynne Schweppe

Psychiatric/Mental Health · Freeport, ILNPI 1821391640

Payments from drug & device makers

$775in general payments, 2019–2025

Across 37 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$168
  • Neurocrine Biosciences, Inc.$123
  • Alkermes, Inc.$118
  • Johnson & Johnson$91
  • Indivior Inc.$81
  • Teva Pharmaceuticals USA, Inc.$71
  • plus $123 from 5 others

What the payments were for

  • Food & beverage$775100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$775 in reported general payments places this provider in the 60th percentile of 922 psychiatric/mental health providers in Illinois.

See all psychiatric/mental health providers in Illinois

Medicare billing

Part B allowed, 2024
$28,614
Medicare patients
73
Services billed
263

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate21$172,526
Invega TrinzaPaliperidone Palmitate11$92,496
Invega SustennaPaliperidone Palmitate26$89,719
Abilify MaintenaAripiprazole20$50,299
PerserisRisperidone15$38,394
Lurasidone Hcl61$30,974
VraylarCariprazine Hcl18$29,927
Aripiprazole153$18,534
VyvanseLisdexamfetamine Dimesylate17$6,729
Ziprasidone Hcl56$5,664
Desvenlafaxine Succinate ErDesvenlafaxine Succinate48$5,545
Quetiapine Fumarate199$3,880
Lisdexamfetamine Dimesylate11$3,465
Trifluoperazine Hcl51$3,236
Hydroxyzine Hcl101$2,792

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$91$182,21537 claims
Neurocrine Biosciences, Inc.Ingrezza$123$172,52621 claims
Indivior Inc.Perseris$81$38,39415 claims
AbbVieVraylar$168$29,92718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 922 psychiatric/mental health providers in Illinois.

Other psychiatric/mental health in Freeport

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →